122 related articles for article (PubMed ID: 10196211)
1. Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion molecules.
Rittershaus CW; Thomas LJ; Miller DP; Picard MD; Geoghegan-Barek KM; Scesney SM; Henry LD; Sen AC; Bertino AM; Hannig G; Adari H; Mealey RA; Gosselin ML; Couto M; Hayman EG; Levin JL; Reinhold VN; Marsh HC
J Biol Chem; 1999 Apr; 274(16):11237-44. PubMed ID: 10196211
[TBL] [Abstract][Full Text] [Related]
2. Endothelial targeting and enhanced antiinflammatory effects of complement inhibitors possessing sialyl Lewisx moieties.
Mulligan MS; Warner RL; Rittershaus CW; Thomas LJ; Ryan US; Foreman KE; Crouch LD; Till GO; Ward PA
J Immunol; 1999 Apr; 162(8):4952-9. PubMed ID: 10202042
[TBL] [Abstract][Full Text] [Related]
3. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
[TBL] [Abstract][Full Text] [Related]
4. Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technology.
Thomas LJ; Panneerselvam K; Beattie DT; Picard MD; Xu B; Rittershaus CW; Marsh HC; Hammond RA; Qian J; Stevenson T; Zopf D; Bayer RJ
Glycobiology; 2004 Oct; 14(10):883-93. PubMed ID: 15190008
[TBL] [Abstract][Full Text] [Related]
5. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein.
Huang J; Kim LJ; Mealey R; Marsh HC; Zhang Y; Tenner AJ; Connolly ES; Pinsky DJ
Science; 1999 Jul; 285(5427):595-9. PubMed ID: 10417391
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage.
Gralinski MR; Wiater BC; Assenmacher AN; Lucchesi BR
Immunopharmacology; 1996 Sep; 34(2-3):79-88. PubMed ID: 8886851
[TBL] [Abstract][Full Text] [Related]
7. Characterization of N-linked oligosaccharides bearing sialyl lewis x moieties on an alternatively glycosylated form of soluble complement receptor type 1 (sCR1).
Picard MD; Pettey CL; Marsh HC; Thomas LJ
Biotechnol Appl Biochem; 2000 Feb; 31(1):5-13. PubMed ID: 10669397
[TBL] [Abstract][Full Text] [Related]
8. sLex is not responsible for the interaction of sLex-positive memory T lymphocytes with E-selectin.
Rotteveel FT; van Doornmalen AM; van Duin M
Immunology; 1995 Sep; 86(1):34-40. PubMed ID: 7590879
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of an E-selectin ligand (SLex) by two Chinese hamster ovary cell lines transfected with the same alpha (1,3)-fucosyltransferase gene (ELFT).
Goelz S; Kumar R; Potvin B; Sundaram S; Brickelmaier M; Stanley P
J Biol Chem; 1994 Jan; 269(2):1033-40. PubMed ID: 7507103
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analysis of P-selectin-sialyl LewisX binding interactions. Mutagenic alteration of ligand binding specificity.
Revelle BM; Scott D; Kogan TP; Zheng J; Beck PJ
J Biol Chem; 1996 Feb; 271(8):4289-97. PubMed ID: 8626776
[TBL] [Abstract][Full Text] [Related]
11. Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells.
Welply JK; Abbas SZ; Scudder P; Keene JL; Broschat K; Casnocha S; Gorka C; Steininger C; Howard SC; Schmuke JJ
Glycobiology; 1994 Jun; 4(3):259-65. PubMed ID: 7524825
[TBL] [Abstract][Full Text] [Related]
12. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation.
Nelson RM; Cecconi O; Roberts WG; Aruffo A; Linhardt RJ; Bevilacqua MP
Blood; 1993 Dec; 82(11):3253-8. PubMed ID: 7694675
[TBL] [Abstract][Full Text] [Related]
13. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins.
Wagers AJ; Stoolman LM; Craig R; Knibbs RN; Kansas GS
J Immunol; 1998 May; 160(10):5122-9. PubMed ID: 9590264
[TBL] [Abstract][Full Text] [Related]
14. Selectin ligands on human melanoma cells.
Miller N; Vile RG; Hart IR
Glycoconj J; 1996 Feb; 13(1):33-43. PubMed ID: 8785485
[TBL] [Abstract][Full Text] [Related]
15. Regulation of PSGL-1 interactions with L-selectin, P-selectin, and E-selectin: role of human fucosyltransferase-IV and -VII.
Martinez M; Joffraud M; Giraud S; Baïsse B; Bernimoulin MP; Schapira M; Spertini O
J Biol Chem; 2005 Feb; 280(7):5378-90. PubMed ID: 15579466
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of P-selectin binding activity by en bloc transfer of sulfo Le(x) trisaccharide to the cell surface: comparison to a sialyl Le(x) tetrasaccharide transferred on the cell surface.
Tsuboi S; Srivastava OP; Palcic MM; Hindsgaul O; Fukuda M
Arch Biochem Biophys; 2000 Feb; 374(1):100-6. PubMed ID: 10640402
[TBL] [Abstract][Full Text] [Related]
17. Construction of the plasmid, expression by Chinese hamster ovary cell, purification and characterization of the first three short consensus repeat modules of human complement receptor type 1.
Yamaguchi A; Takagawa H; Iwakaji H; Miyagawa S; Wang PC; Ishii N
J Biochem; 2009 Apr; 145(4):533-42. PubMed ID: 19218189
[TBL] [Abstract][Full Text] [Related]
18. Studies on selectin-carbohydrate interactions.
Jacob GS; Welply JK; Scudder PR; Kirmaier C; Abbas SZ; Howard SC; Keene JL; Schmuke JJ; Broschat K; Steininger C
Adv Exp Med Biol; 1995; 376():283-90. PubMed ID: 8597260
[TBL] [Abstract][Full Text] [Related]
19. Antisense strategies for glycosylation engineering of Chinese hamster ovary (CHO) cells.
Prati EG; Scheidegger P; Sburlati AR; Bailey JE
Biotechnol Bioeng; 1998 Aug; 59(4):445-50. PubMed ID: 10099358
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of the dynamic strength of the sialyl Lewis X--selectin interaction.
Zhang X; Bogorin DF; Moy VT
Chemphyschem; 2004 Feb; 5(2):175-82. PubMed ID: 15038277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
